You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Impact of cyp genotype and serum il-6 on tramadol pharmacokinetics and drug tolerability
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-HPS-126
- By: TANAKA, Hironari (Hamamatsu University School of Medicine, Hospital Pharmacy)
- Co-author(s): Hironari Tanaka
Takafumi Naito: Hospital Pharmacy, Hamamatsu University School of Medicine, Shizuoka, Japan
Hikaru Sato: Hospital Pharmacy, Hamamatsu University School of Medicine, Shizuoka, Japan
Takanori Hiraide: Clinical Oncology, Hamamatsu University School of Medicine, Shizuoka, Japan
Yasuhide Yamada: Clinical Oncology, Hamamatsu University School of Medicine, Shizuoka, Japan
Junichi Kawakami: Hospital Pharmacy, Hamamatsu University School of Medicine, Shizuoka, Japan - Abstract:
Background
Clinical responses to oral tramadol show a large variation in cancer patients.Methods
Seventy Japanese cancer patients treated with oral tramadol were enrolled. The predose plasma concentrations of tramadol and its desmethylates were determined at day 4 or later after starting the medication. CYP2D6, CYP2B6, and CYP3A5 genotypes, serum.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026